Skip to main content
. 2018 Feb 12;15(4):376–384. doi: 10.7150/ijms.22823

Fig 2.

Fig 2

SERPINB5 immunostaining of representative sections revealed (A) low immunoreactivity in normal colonic mucosa, (B) weak cytoplasmic expression in the low-stage tumors that showed a positive response to neoadjuvant CCRT, and (C) strong combined cytoplasmic and nuclear expression in the high-stage tumors that showed resistance to CCRT.